Context Therapeutics Inc. (CNTX) SEC Filings — 2024
27 SEC filings for Context Therapeutics Inc. (CNTX) in 2024.
Filings
- Context Therapeutics Files 8-K — 8-K · Dec 23, 2024
- Context Therapeutics Inc. Files 8-K: Material Agreement Announced — 8-K · Dec 2, 2024
- Context Therapeutics Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Context Therapeutics Inc. SC 13G Filing — SC 13G · Nov 14, 2024
- Context Therapeutics Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Context Therapeutics Inc. SC 13G/A Filing — SC 13G/A · Nov 6, 2024
- Context Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 6, 2024
- Context Therapeutics Files 8-K: Material Agreement & Disclosures — 8-K · Sep 23, 2024
- Context Therapeutics Files 8-K — 8-K · Sep 17, 2024
- Context Therapeutics Appoints New Director — 8-K · Sep 4, 2024
- Context Therapeutics Files 10-Q for Q2 2024 — 10-Q · Aug 7, 2024
- Context Therapeutics Inc. files 2024 Proxy Statement — DEF 14A · Jul 24, 2024
- Context Therapeutics Enters Material Definitive Agreement — 8-K · Jul 10, 2024
- Context Therapeutics Inc. Files 8-K on Shareholder Votes — 8-K · Jun 14, 2024
- Context Therapeutics Inc. SC 13G Filing — SC 13G · Jun 5, 2024
- Context Therapeutics Inc. SC 13G Filing — SC 13G · May 24, 2024
- Context Therapeutics Inc. SC 13G Filing — SC 13G · May 13, 2024
- Context Therapeutics Inc. SC 13G Filing — SC 13G · May 10, 2024
- Context Therapeutics Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 8, 2024
- Context Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · May 2, 2024
- Context Therapeutics Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 26, 2024
- Context Therapeutics Files 8-K with Corporate Updates — 8-K · Apr 1, 2024
- Context Therapeutics Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 21, 2024
- Context Therapeutics Files 8-K: Material Agreement & Reg FD — 8-K · Mar 6, 2024
- Context Therapeutics Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Martin Lehr Amends Context Therapeutics Stake, Reports 820K Shared Voting Power — SC 13G/A · Feb 7, 2024
- Opaleye Management Takes 9.99% Stake in Context Therapeutics — SC 13G · Jan 5, 2024